41 episodes

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice Endocrinology & Metabolic Disorders Audio PeerVoice

    • Science
    • 2.8 • 5 Ratings

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

    A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes

    A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes

    Visit https://www.peervoice.com/XXB860 to view the entire programme with slides. After completing “A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes”, participants will be able to: Describe common challenges to multidisciplinary care for patients with type 2 diabetes (T2DM) who are suffering from, or at high risk of, chronic kidney disease (CKD); Analyse recent data for SGLT2 inhibitors and GLP-1 receptor agonists in the management of patients with T2DM and CKD; Propose strategies to improve communication and collaboration among the multidisciplinary team.

    • 28 min
    Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies

    Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies

    Visit https://www.peervoice.com/PUS860 to view the entire programme with slides. After completing “Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies”, participants will be able to: Explain how adeno-associated virus (AAV)–based gene therapy is revolutionising medicine; Differentiate between in vivo and ex vivo gene therapies; Summarise the key features of a condition/disorder that could make it suitable for an AAV-based gene therapy approach; Discuss the key ethical issues surrounding gene therapy; Describe the differences in the safety profile of non-integrating vs integrating gene therapy vectors; Identify the conditions/disorders where there are ongoing clinical trials with AAV-based gene therapies.

    • 15 min
    The Holistic Care of Patients with T2DM: Going Beyond HbA1c

    The Holistic Care of Patients with T2DM: Going Beyond HbA1c

    Visit https://www.peervoice.com/FTG860 to view the entire programme with slides. After completing “The Holistic Care of Patients with T2DM: Going Beyond HbA1c”, participants will be able to: Discuss emerging clinical evidence for incretin therapies for type 2 diabetes (T2DM) and how these data may impact future management strategies; Describe the function of incretin hormones and their role in the pathogenesis of T2DM; Recognise the benefits of incretin therapies beyond glycaemic control in patients with T2DM; Apply best practices for the holistic management of patients with T2DM.

    • 23 min
    Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care

    Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care

    Visit https://www.peervoice.com/QNV860 to view the entire programme with slides. After completing “Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care”, participants will be able to: Recognise the common barriers to add-on therapy for patients with type 2 diabetes (T2DM) in the primary care setting and consequences of undertreatment; Evaluate current clinical trial data for GLP-1 receptor agonists (RAs) in the management of patients with T2DM; Design strategies to address key barriers to optimal, evidence-based treatment algorithms for patients with T2DM.

    • 25 min
    Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!

    Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!

    Visit https://www.peervoice.com/DMU860 to view the entire programme with slides. After completing “Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!”, participants will be able to: Discuss the place in therapy for traditional oral glucose-lowering medications and the rationale for their continued use; Appraise the recent data on cardiovascular safety and hypoglycaemia associated with sulphonylureas (SUs); Identify factors that would indicate suitability of a patient with type 2 diabetes for an SU and how treatment could be individualised to optimise outcomes.

    • 17 min
    Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes

    Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes

    Visit https://www.peervoice.com/JTM860 to view the entire programme with slides. After completing “Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes”, participants will be able to: Describe unmet needs for patients with type 2 diabetes (T2DM) and obesity; Explain safety and efficacy of pharmacologic options for the management of patients with T2DM and obesity, such as incretins; Develop individualised therapeutic goals and strategies to improve outcomes for patients with T2DM and obesity.

    • 31 min

Customer Reviews

2.8 out of 5
5 Ratings

5 Ratings

Top Podcasts In Science

You Might Also Like

More by PeerVoice